Cigna Corp.’s acquisition by health-insurance rival Anthem Inc. may not be approved this year, Cigna said Friday in a regulatory filing.
Shares of both companies declined. An analyst said the delay could be a sign of trouble for the deal, which is one of two pending health-insurance combinations being scrutinized by regulators who have expressed concern about further concentration of the health-care industry.
Read Full Article »